1. Home
  2. TEX vs NAMS Comparison

TEX vs NAMS Comparison

Compare TEX & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Terex Corporation

TEX

Terex Corporation

HOLD

Current Price

$50.18

Market Cap

3.0B

Sector

Industrials

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$36.06

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TEX
NAMS
Founded
1933
2019
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TEX
NAMS
Price
$50.18
$36.06
Analyst Decision
Buy
Strong Buy
Analyst Count
10
10
Target Price
$56.20
$45.80
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
10-30-2025
11-05-2025
Dividend Yield
1.37%
N/A
EPS Growth
N/A
N/A
EPS
2.34
N/A
Revenue
$5,344,000,000.00
$35,243,000.00
Revenue This Year
$6.98
N/A
Revenue Next Year
$4.25
N/A
P/E Ratio
$21.19
N/A
Revenue Growth
4.60
4.91
52 Week Low
$31.53
$14.06
52 Week High
$58.66
$42.00

Technical Indicators

Market Signals
Indicator
TEX
NAMS
Relative Strength Index (RSI) 60.57 44.47
Support Level $45.44 $34.52
Resistance Level $46.64 $42.00
Average True Range (ATR) 1.82 2.20
MACD 0.89 -0.54
Stochastic Oscillator 94.09 20.45

Price Performance

Historical Comparison
TEX
NAMS

About TEX Terex Corporation

Terex is a global manufacturer of aerial work platforms, materials processing equipment, and specialty equipment for the waste, recycling, and utility industries. Its current composition is a result of numerous acquisitions over several decades to focus on a smaller group of light construction and other vocational equipment, having divested a handful of underperforming businesses, particularly in cranes and other lifting equipment. These remaining segments see heavy demand in nonresidential construction (aerial work platforms—40% sales), aggregates/mining (materials processing—30% sales), environmental, waste/recycling and utilities (environmental solutions group—30% sales).

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: